Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S6 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
  1. Home
  2. Publications
  3. Supplementary Figure S6 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling

Supplementary Figure S6 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling

Authors:
  • YSYongjing Shi
    Yongjing Shi
  • XZXiaodong Zheng
    Xiaodong Zheng
  • HPHui Peng
    Hui Peng
  • CXChenqi Xu
    Chenqi Xu
  • RSRui Sun
    Rui Sun
  • ZTZhigang Tian
    Zhigang Tian
  • HSHaoyu Sun
    Haoyu Sun
  • XWXianwei Wang
    Xianwei Wang

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.32701094
Abstract
Supplementary Figure S6. FBXO38 deficiency increases the expression of suppressors of cell cycle program in TINK cells
Keywords
  • IMMUNOLOGY
  • NK CELLS
  • IMMUNOTHERAPY
  • CELLULAR IMMUNOTHERAPY
  • TUMOR MICROENVIRONMENT
  • IMMUNE CELLS AND THE MICROENVIRONMENT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.